What move does the options market price into Galectin Therapeutics's report?

Implied ±40.0%, either direction.

GALTNasdaqPharmaceutical Preparations

Galectin Therapeutics Inc (GALT) earnings date, market-implied expected move, and options open interest by expiry

3.46

+0.11 · +3.42%

post 3.46 0.00%

Closed16:00 ET

Open3.46Volume118,235Mkt cap$337.8MEPS-0.43

Day3.45 – 3.5029%52-wk2.03 – 7.1328%

GALT

Galectin Therapeutics Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±40.0%implied · report alone

2.084.86

straddle ±42.9%

spot 3.47exp Nov 20ATM strike 2.5ATM straddle 1.75IV 293%

Nov 4 closereport share · term structure

Expected move

Inputs

Next report

Nov 13

before open · in 9 days

est.Q3 FY26

Calendar

Next report

Last report

−2.55%

vs ±26.6% implied · ×0.10

shaded = implied · ▲▼ = realized

Aug 14 '26 · confirmed

Implied vs realized

Largest filed tie

—

Supply chain

13F top-10 QoQ

+40.13%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

101 managers

Top fund weight

0.01%

GALT weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Galectin Therapeutics (GALT) is expected to report on Nov 13 before open (estimated date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 14 '26confirmed±26.6%▼−2.55%×0.10

quarterimplied−30%0+30%realized×

Q2 FY26±26.6%▼−2.55%×0.10

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Oct 28 close

0.10OI · 3 expiries · Oct 28 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

1260%Nov 2016d1,286+10%

0—Dec 1844d0.00131—0.00

1,1130%Jan 1572d0.195,885+13%0.19

ExpiryPutsCallsP/C

Nov 2016d1260%1,286+10%0.10

Dec 1844d0—131—0.00

Jan 1572d1,1130%5,885+13%0.19

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±42.9%

Funds 3

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 4 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

PPI ×1.65· ±6.4% vs ±3.9% · 10 releases

eventrelease day|move|up · n×base

PPIproducer prices±6.4%3 of 10×1.65

FOMCrate decision±5.2%11 of 24×1.34

CPROFcorporate profits±5.1%6 of 12×1.33

GDPgross domestic product±4.6%10 of 19×1.18

PCEpersonal income & outlays±4.4%10 of 19×1.15

CPIconsumer prices±3.6%4 of 10×0.93

NFPjobs report±3.2%5 of 10×0.83

Bar = avg |move| to ±7% · tick = ±3.9% avg day · ×base = |move| ÷ ±3.9% · min 6 releases

Earnings history

EPS -0.14 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 14 '26 · confirmed	-0.14	—
Q1 FY26	—	-0.08	—
Q3 FY25	—	-0.13	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod